secwatch.observer — SEC 8-K summary
======================================

Issuer:     MYRIAD GENETICS INC (MYGN)
CIK:        0000899923
Form:       8-K
Filed at:   2023-12-21T23:59:59+00:00
Accession:  0000899923-23-000117
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Myriad Genetics CFO Bryan Riggsbee retires; Scott Leffler named successor effective Jan 29, 2024
--------------------------------------------------------------------------------

- Riggsbee steps down as CFO by Jan 31, 2024; will serve as strategic advisor through March 31, 2024.
- New CFO Scott Leffler appointed effective Jan 29, 2024; previously CFO at Clover Health and Sotera Health.
- Leffler receives base salary $550k, target bonus 75%, sign-on bonus $400k, and initial RSU grants totaling $2.5M.
- Company reiterates 2023 and 2024 financial guidance previously issued on Nov 6, 2023.
- Departure not due to disagreements; separation includes consulting fee $2,713.65/week and continued equity vesting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/899923/000089992323000117/0000899923-23-000117-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/899923/000089992323000117/mygn-20231215.htm
  HTML page:      https://secwatch.observer/filing/0000899923-23-000117

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer